Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
152M
-
Shares change
-
+24.4M
-
Total reported value, excl. options
-
$305M
-
Value change
-
+$48M
-
Put/Call ratio
-
0.85
-
Number of buys
-
97
-
Number of sells
-
-64
-
Price
-
$2.01
Significant Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2022
236 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - COMMON STOCK as of Q2 2022.
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 152M shares
.
Largest 10 shareholders include STATE STREET CORP (39.7M shares), BlackRock Inc. (34M shares), VANGUARD GROUP INC (20.9M shares), GEODE CAPITAL MANAGEMENT, LLC (6.89M shares), D. E. Shaw & Co., Inc. (5.88M shares), NORTHERN TRUST CORP (3.45M shares), JPMORGAN CHASE & CO (3.27M shares), MORGAN STANLEY (2.97M shares), NORGES BANK (2.9M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.77M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.